Research records indexed for CJC-1295
This page carries 12 of the 36 records that the literature query returned for CJC-1295, selected by citation count and preferring records that name the compound in their title. It is a selection, not a complete index, and the 24 records it does not carry are not represented here. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is CJC-1295.
Indexed records
| Record | Year | Study type | Model | n as stated | What it reported |
|---|---|---|---|---|---|
| Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance pmid:41966639 | 2026 | Review | other | Not stated | Indexed as review. compound named in the abstract, not the title. study model from MeSH "Animals" with no rodent species heading. subject headings: Musculoskeletal System; Athletic Injuries; Peptides; Peptide Fragments; Athletic Performance. |
| Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians pmid:41476424 | 2026 | Review | other | Not stated | Indexed as review. compound named in the abstract, not the title. study model from MeSH "Animals" with no rodent species heading. subject headings: Athletic Injuries; Peptides; Injections, Intra-Articular; Orthopedics; Sports Medicine. |
| Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions pmid:41490200 | 2026 | review-article, Review | other | Not stated | Indexed as review-article, review. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Peptides; Wound Healing; Signal Transduction. |
| An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma pmid:30489688 | 2019 | Validation Study | other | Not stated | Indexed as validation study. study model from MeSH "Animals" with no rodent species heading. subject headings: Horses; Peptide Fragments; Antibodies, Monoclonal; Immunoassay; Surface Plasmon Resonance. |
| A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS pmid:30938069 | 2019 | Validation Study | other | Not stated | Indexed as validation study. study model from MeSH "Animals" with no rodent species heading. subject headings: Horses; Hormones; Peptide Fragments; Serum Albumin; Chromatography, Liquid. |
| Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions pmid:26771670 | 2016 | Review | other | Not stated | Indexed as review. study model from MeSH "Humans" with no interventional publication type. subject headings: Human Growth Hormone; Peptide Fragments; Self Care; Body Image; Decision Making. |
| Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation pmid:21204297 | 2010 | Journal Article | other | Not stated | Indexed as journal article. study model from assigned MeSH headings do not state a study model. subject headings: Peptide Fragments; Pharmaceutical Preparations; Chromatography, Liquid; Growth Hormone-Releasing Hormone; Tandem Mass Spectrometry. |
| Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects pmid:19386527 | 2009 | Research Support, Non-U.S. Gov't, research-article | other | Not stated | Indexed as research support, non-u.s. gov't, research-article. study model from MeSH "Humans" with no interventional publication type. subject headings: Pituitary Gland; Hypothalamus; Growth Hormone; Insulin-Like Growth Factor I; Peptide Fragments. |
| Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults pmid:16352683 | 2006 | Research Support, Non-U.S. Gov't, Randomized Controlled Trial | human trial | Not stated | Indexed as research support, non-u.s. gov't, randomized controlled trial. study model from MeSH "Humans" with publication type "randomized controlled trial". subject headings: Human Growth Hormone; Insulin-Like Growth Factor I; Peptide Fragments; Placebos; Injections, Subcutaneous. |
| Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog pmid:17018654 | 2006 | Clinical Trial, Research Support, Non-U.S. Gov't | human trial | Not stated | Indexed as clinical trial, research support, non-u.s. gov't. study model from MeSH "Humans" with publication type "clinical trial". subject headings: Growth Hormone; Insulin-Like Growth Factor I; Peptide Fragments; Injections; Pulsatile Flow. |
| Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse pmid:16822960 | 2006 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Mice, Inbred C57bl". subject headings: Femur; Tibia; Pituitary Gland; Mice, Inbred C57BL; Mice, Knockout. |
| Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog pmid:15817669 | 2005 | Journal Article | rodent | Not stated | Indexed as journal article. study model from MeSH "Rats". subject headings: Pituitary Gland, Anterior; Cells, Cultured; Rats, Sprague-Dawley; Sermorelin; Peptide Fragments. |
Where this page sits
Compound page: CJC-1295. Class: GHRH analogues.
Retrieved 2026-10-10.
Sources
- PubChem Compound Summary for CID 91971820, Cjc 1295. PubChem, National Library of Medicine (2026). pubchem:91971820
- Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:cjc-1295
- Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology (2005). pmid:15817669
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab (2006). pmid:16352683
- Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab (2006). pmid:17018654
- Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Growth Horm IGF Res (2009). pmid:19386527
- Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation. Drug Test Anal (2010). pmid:21204297
On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.